Literature DB >> 17330072

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.

Christopher J H Porter1, Natalie L Trevaskis, William N Charman.   

Abstract

Highly potent, but poorly water-soluble, drug candidates are common outcomes of contemporary drug discovery programmes and present a number of challenges to drug development - most notably, the issue of reduced systemic exposure after oral administration. However, it is increasingly apparent that formulations containing natural and/or synthetic lipids present a viable means for enhancing the oral bioavailability of some poorly water-soluble, highly lipophilic drugs. This Review details the mechanisms by which lipids and lipidic excipients affect the oral absorption of lipophilic drugs and provides a perspective on the possible future applications of lipid-based delivery systems. Particular emphasis has been placed on the capacity of lipids to enhance drug solubilization in the intestinal milieu, recruit intestinal lymphatic drug transport (and thereby reduce first-pass drug metabolism) and alter enterocyte-based drug transport and disposition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330072     DOI: 10.1038/nrd2197

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  249 in total

1.  The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulations.

Authors:  Ahmad Abdul-Wahhab Shahba; Kazi Mohsin; Fars Kaed Alanazi
Journal:  AAPS PharmSciTech       Date:  2012-03-23       Impact factor: 3.246

2.  Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallization.

Authors:  Yan Li; Jinkai Zheng; Hang Xiao; David Julian McClements
Journal:  Food Hydrocoll       Date:  2011-09-17       Impact factor: 9.147

Review 3.  Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?

Authors:  Roudayna Diab; Chiraz Jaafar-Maalej; Hatem Fessi; Philippe Maincent
Journal:  AAPS J       Date:  2012-07-06       Impact factor: 4.009

Review 4.  The use of biorelevant dissolution media to forecast the in vivo performance of a drug.

Authors:  Sandra Klein
Journal:  AAPS J       Date:  2010-05-11       Impact factor: 4.009

5.  Predicting the effect of fed-state intestinal contents on drug dissolution.

Authors:  Ece Dilber Gamsiz; Mukul Ashtikar; John Crison; Walt Woltosz; Michael B Bolger; Rebecca Lyn Carrier
Journal:  Pharm Res       Date:  2010-10-21       Impact factor: 4.200

6.  A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations.

Authors:  Matthew F Crum; Natalie L Trevaskis; Hywel D Williams; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2015-12-24       Impact factor: 4.200

7.  Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability.

Authors:  Bilal S Abuasal; Courtney Lucas; Breanne Peyton; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2012-01-24       Impact factor: 1.880

8.  Bioaccessibility of hydroxytyrosol and n-3 fatty acids as affected by the delivery system: simple, double and gelled double emulsions.

Authors:  Susana Cofrades; Ricard Bou; Linda Flaiz; Alba Garcimartín; Juana Benedí; Raquel Mateos; Francisco J Sánchez-Muniz; Raúl Olivero-David; Francisco Jiménez-Colmenero
Journal:  J Food Sci Technol       Date:  2017-05-06       Impact factor: 2.701

Review 9.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

10.  Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS).

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2014-06-17       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.